NeuroImage. Clinical · 2026
Test-retest reliability of resting-state functional magnetic resonance imaging during deep brain stimulation for Parkinson's disease.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Deutsch Skyler, Mehta Juhi, Reid Lee B, Fuentes Andrea, Wang Sarah, Kornak John, Starr Philip A, Ostrem Jill L, Wang Doris D, Bledsoe Ian O, Morrison Melanie A
Аннотация
BACKGROUND: Patients implanted with modern deep brain stimulation (DBS) hardware can now undergo functional magnetic resonance imaging (fMRI), leading to its increased used to study DBS' mechanisms and predict optimal therapy settings. To accurately interpret fMRI data and realize its clinical potential for DBS, a better understanding of reliability is needed.
METHODS: Sixteen patients with Parkinson's disease (PD) and DBS targeting the subthalamic nucleus or pallidum underwent 3T test-retest resting-state fMRI with and without concurrent stimulation. Effects of stimulation and device-metal artifacts on reliability of fMRI brain connectivity and moment-to-moment brain variability were explored, plus factors influencing between-subject variations in reliability such as motion.
RESULTS: The brain variability fMRI metric yielded higher intra-class correlation coefficients than the connectivity metric (range across whole brain, motor, limbic, and cognitive networks: 0.36-0.85 and 0.68-0.99, respectively). Average network connectivity appeared less reproducible when DBS was ON versus OFF during fMRI, and fMRI metric reliability for brain areas affected by metal artifacts was significantly higher (brain variability) or lower (connectivity) than unaffected areas (puncorrected < 0.05). Motion and DBS target best explained between-subject variations.
CONCLUSION: DBS hardware and active stimulation may alter fMRI reliability. To develop clinically useful fMRI biomarkers for DBS and aid assessments of reproducibility across studies, the reliability of single study results need reporting.
METHODS: Sixteen patients with Parkinson's disease (PD) and DBS targeting the subthalamic nucleus or pallidum underwent 3T test-retest resting-state fMRI with and without concurrent stimulation. Effects of stimulation and device-metal artifacts on reliability of fMRI brain connectivity and moment-to-moment brain variability were explored, plus factors influencing between-subject variations in reliability such as motion.
RESULTS: The brain variability fMRI metric yielded higher intra-class correlation coefficients than the connectivity metric (range across whole brain, motor, limbic, and cognitive networks: 0.36-0.85 and 0.68-0.99, respectively). Average network connectivity appeared less reproducible when DBS was ON versus OFF during fMRI, and fMRI metric reliability for brain areas affected by metal artifacts was significantly higher (brain variability) or lower (connectivity) than unaffected areas (puncorrected < 0.05). Motion and DBS target best explained between-subject variations.
CONCLUSION: DBS hardware and active stimulation may alter fMRI reliability. To develop clinically useful fMRI biomarkers for DBS and aid assessments of reproducibility across studies, the reliability of single study results need reporting.